AGC Biologics Expands Partnership with Novavax
NVX-CoV2373 is a stable, prefusion protein made using
"We are extremely proud that
"We are pleased to expand our partnership with AGC Biologics into
"We are very happy to have the opportunity to serve
AGC Biologics' global network spans three continents, with cGMP-compliant facilities in
About AGC Biologics:
AGC Biologics is a leading global
AGC Biologics offers deep industry expertise and unique customized services. Integrated service offerings include cell line development, bioprocess development, formulation, analytical testing, antibody drug development and conjugation, cell banking and storage and protein expression, including the proprietary CHEF1® Expression System for mammalian production.
AGC Biologics is committed to continuous innovation and offers the technical creativity to solve clients' most complex challenges, including specialization in fast-track projects for orphan drugs and rare diseases. Learn more at www.agcbio.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/agc-biologics-expands-partnership-with-novavax-301109376.html
SOURCE AGC Biologics
Diane Hunt, firstname.lastname@example.org, http://www.agcbio.com/